Yinwan Huayi No. 1 Private Securities Investment Fund managed by Zhejiang Invest Equity Investment & Management Co., Ltd. agreed to acquire 5% stake in Shanghai Xuerong Biotechnology Co.,Ltd. (SZSE:300511) from Yang Yongping for CNY134 million on November 15, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.61 CNY | -1.14% | -3.33% | -51.21% |
Jun. 12 | Xuerong Biotechnology Chairman Detained; Shares Plunge 10% | MT |
Apr. 25 | Shanghai Xuerong Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-51.21% | 180M | |
+25.00% | 1.11B | |
-.--% | 780M | |
+0.69% | 720M | |
-45.26% | 502M | |
+6.68% | 372M | |
-25.60% | 318M | |
-0.29% | 302M | |
+9.09% | 258M | |
-39.73% | 242M |
- Stock Market
- Equities
- 300511 Stock
- News Shanghai Xuerong Biotechnology Co.,Ltd.
- Yinwan Huayi No. 1 Private Securities Investment Fund managed by Zhejiang Invest Equity Investment & Management Co., Ltd. agreed to acquire 5% stake in Shanghai Xuerong Biotechnology Co.,Ltd. from Yang Yongping for CNY134 million.